Related Experiment Videos
Canine hemangiosarcoma: retrospective analysis of 104 cases
Journal of the American Veterinary Medical Association
|January 1, 1985
Summary
Hemangiosarcoma in dogs, a common cancer in German Shepherds and Poodles, often affects the spleen. Treatment options like surgery and chemotherapy showed no significant difference in survival outcomes for canine hemangiosarcoma.
Area of Science:
- Veterinary Oncology
- Canine Cancer Research
- Surgical Pathology
Background:
- Hemangiosarcoma is a prevalent and aggressive malignancy in dogs.
- Splenic tumors are a common presentation of canine hemangiosarcoma.
- Rupture or metastasis often leads to clinical presentation.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of canine hemangiosarcoma.
- To evaluate the impact of treatment modalities and clinical staging on survival.
- To provide data on the prognosis of dogs diagnosed with hemangiosarcoma.
Main Methods:
- Retrospective case series of 104 dogs diagnosed with hemangiosarcoma.
- Data collection included signalment, tumor location, clinical presentation, treatment, and survival time.
- Statistical analysis was performed to compare survival based on therapy and clinical stage.
Main Results:
- The mean age of affected dogs was 10 years, with German Shepherds and Poodles being most common breeds.
- The spleen was the most frequent primary tumor site (65/104).
- Survival was poor, with a mean survival time of 123 days for dogs not euthanized at diagnosis; no significant difference was found between treatment groups or stages.
Conclusions:
- Canine hemangiosarcoma, particularly splenic, carries a grave prognosis.
- Current treatment strategies (surgery, immunotherapy, chemotherapy) and clinical staging did not significantly alter survival times.
- Further research into novel therapeutic approaches is warranted for canine hemangiosarcoma.